Oncogenes and signalling pathways Flashcards

(30 cards)

1
Q

What are proto-oncogenes?

A

Genes that normally regulate cell growth and differentiation; can become oncogenes when mutated or misregulated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do proto-oncogenes activate transcription?

A

Through products like transcription factors (e.g., Myc, Fos, Jun) that bind DNA and promote expression of cell cycle genes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which transcription factor family is formed by Fos and Jun?

A

AP-1 (activator protein-1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens when c-Myc is amplified?

A

Overexpression drives uncontrolled cell proliferation (e.g., in neuroblastoma, SCLC).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is Ras activated?

A

By GEFs like Sos, which replace GDP with GTP on Ras following RTK activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is Ras inactivated?

A

By GAPs (e.g., NF1), which stimulate GTP hydrolysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does active Ras-GTP recruit?

A

Raf to the membrane → initiates MAPK cascade.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens when Ras is mutated (e.g., codon 12)?

A

It can’t hydrolyze GTP → remains active → promotes cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the MAPK pathway sequence?

A

Ras → Raf → MEK → MAPK → transcription factors → cell proliferation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What do integrins do?

A

Connect cells to ECM, regulate motility, and signal through pathways like Ras-ERK.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is “inside-out” signaling?

A

Cytoplasmic signals change integrin conformation to increase ligand affinity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is “outside-in” signaling?

A

ECM binding activates intracellular signaling for migration, survival, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name integrin signaling proteins.

A

FAK, Src-family kinases, ILK, paxillin, vinculin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is TGF-β’s dual role?

A

Tumor suppressor (induces apoptosis); tumor promoter (invasion, EMT).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which genes are up/downregulated by TGF-β?

A

Up: p15, p21, MMPs, Snail; Down: c-Myc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does the β-catenin destruction complex do?

A

Targets β-catenin for degradation (APC, axin, GSK3, CK1).

17
Q

What happens when Wnt binds Frizzled + LRP5/6?

A

Inhibits degradation complex → β-catenin accumulates → transcriptional activation.

18
Q

Which residues promote β-catenin degradation?

A

Ser33, Ser37, Thr41 (phosphorylated by GSK3β).

19
Q

What physiological functions involve GPCRs?

A

Neurotransmission, immunity, cardiac function, hormone release.

20
Q

What does PGE2 do in colon cancer?

A

Activates EP2 receptor (Gαs-coupled) → promotes tumor progression.

21
Q

What causes Gorlin syndrome?

A

Loss-of-function mutation in PTCH1 → constitutive Hh activation.

22
Q

Tumors linked to Hh pathway dysregulation?

A

Basal cell carcinoma, medulloblastoma, rhabdomyosarcoma.

23
Q

List the 5 models of Hh pathway activation in cancer.

A

Type 1: ligand-independent, Type 2: autocrine, Type 3: paracrine, 3b: reverse paracrine, CSC model.

24
Q

What are Notch pathway target genes?

A

Hes1/5, Hey1, CD25, GATA3, c-Myc, cyclin D1, p21, Bcl2, etc.

25
What cancer is associated with Notch1 mutation?
T-cell acute lymphoblastic leukemia (T-ALL)
26
What is TAN1?
A truncated, constitutively active Notch1 allele.
27
How has understanding oncogenes led to therapy development?
Enabled drugs targeting specific mutations or pathway components.
28
Example: HER2-targeted therapy?
Trastuzumab (Herceptin) for HER2+ breast cancer.
29
Example: Bcr-Abl-targeted therapy?
Imatinib (Gleevec) for CML.
30
What do EGFR inhibitors target?
Constitutively active or overexpressed EGFR in cancers (e.g., lung, colorectal).